Pharmaceutical

Vistagen obtains Canadian Notice of Allowance for AV-101 patent

Vistagen has received a Canadian Notice of Allowance for patent that is related to the use of AV-101 in Parkinson's disease (PD) patients.

Jul 15, 2023 - 20:00
Vistagen obtains Canadian Notice of Allowance for AV-101 patent
Vistagen has received a Canadian Notice of Allowance for patent that is related to the use of AV-101 in Parkinson's disease (PD) patients.
Read the original article

Tags:

Previous Article

Theseus terminates its GI cancer drug development programme

Next Article

Gilead, CHAI and Penta to enhance HIV treatment for children

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Rentschler Biopharma and Ikarovec partner to expedite new gene therapies

Rentschler Biopharma and Ikarovec partner to expedite n...

Jun 3, 2023

STAT+: Lawmakers circle parents’ rights in gender-affirming care hearing

STAT+: Lawmakers circle parents’ rights in gender-affir...

Jul 30, 2023

How did hiring in the Chinese pharma industry perform in Q2 2023

How did hiring in the Chinese pharma industry perform i...

Jul 29, 2023